Clinical trialNCT03028246RecruitingInterventional

A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects

SponsorInSightecEnrollment20Benign Centrally-Located Intracranial Tumors

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this prospective, non-randomized, single-arm, feasibility study is to develop data to evaluate the safety and feasibility of ExAblate 4000 treatment of benign intracranial tumors which require clinical intervention in pediatric and young adult subjects. Indication of Use: Ablation of benign intracranial tumors in children and young adults which are ExAblate accessible.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

John Ragheb, MD
Miami Children's Research Institute - Nicklaus Children's Hospital
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Children'S National Medical Center
Washington D.C., District of Columbia, United States
Robert KeatingRoger Packer
Recruiting
Nicklaus Children'S Hospital
Miami, Florida, United States
John Ragheb, MDMarytery Fajardo, MDMatt Lallas, MDPat Dean, ARNP
Recruiting
Texas Children'S Hospital
Houston, Texas, United States
Daniel Curry, MDIrfan Ali, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Feb 2017
Primary completion: 31 Dec 2026
Completion: 31 Dec 2026
Last update posted: 29 Jun 2026
Registered enrollment: 20
Registry id: NCT03028246

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.